scholarly journals EVALUATION OF FUNCTIONAL PARAMETERS OF RESPIRATORY SYSTEM IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN 6-MINUTE WALKING TEST

2019 ◽  
Vol 7 (3) ◽  
pp. 323-331 ◽  
Author(s):  
V.N. Abrosimov ◽  
◽  
N.N. Peregudova ◽  
A.V. Kosyakov ◽  
◽  
...  
2007 ◽  
Vol 14 (2) ◽  
pp. 93-98 ◽  
Author(s):  
Louis Laviolette ◽  
Yves Lacasse ◽  
Mariève Doucet ◽  
Miriam Lacasse ◽  
Karine Marquis ◽  
...  

BACKGROUND: Little is known about the comparative impact of chronic obstructive pulmonary disease (COPD) between women and men and about women’s response to pulmonary rehabilitation.OBJECTIVES: To compare lung function, disability, mortality and response to pulmonary rehabilitation between women and men with COPD.METHODS: In the present retrospective study, 68 women (mean age 62.5±8.9 years) and 168 men (mean age 66.3±8.4 years) were evaluated by means of pulmonary function testing and an incremental symptom-limited cycle exercise test. Forty women and 84 men also participated in a 12-week pulmonary rehabilitation program. A 6 min walking test and the chronic respiratory questionnaire were used to assess the effects of pulmonary rehabilitation. Survival status was also evaluated.RESULTS: Compared with men, women had a smaller tobacco exposure (31±24 versus 48±27 pack-years, P<0.05), displayed better forced expiratory volume in 1 s (44±13 versus 39±14 % predicted, P<0.05), a higher functional residual capacity (161±37 versus 149±36 % predicted, P<0.05) and total lung capacity (125±20 versus 115±19 % predicted, P<0.001). Peak oxygen consumption was not different between women and men when expressed in predicted values but lower in women when expressed in absolute values. Pulmonary rehabilitation resulted in significant improvements in 6 min walking test and quality of life in both sexes, but women had a greater improvement in chronic respiratory questionnaire dyspnea. Survival status was similar between sexes, but predictors of mortality were different between sexes.CONCLUSIONS: Women may be more susceptible to COPD than men. The clinical expression of COPD may differ between sexes with greater degree of hyperinflation in women, who also benefit from pulmonary rehabilitation.


2013 ◽  
Vol 187 (12) ◽  
pp. 1315-1323 ◽  
Author(s):  
Roberto C. Chin ◽  
Jordan A. Guenette ◽  
Sicheng Cheng ◽  
Natya Raghavan ◽  
Naparat Amornputtisathaporn ◽  
...  

2020 ◽  
Vol 27 (4) ◽  
pp. 451-457
Author(s):  
Aleksey V. Kosyakov ◽  
Vladimir N. Abrosimov

Aim. To evaluate changes in the cardiointervalogram (CIG) in the test with external peripheral vascular occlusion in patients with chronic obstructive pulmonary disease (COPD) and in individuals without diseases of the respiratory system. Materials and Methods. The study included 105 men, of them 64 patients with COPD (age 64.988.67) and 41 volunteers without diseases of the respiratory system (age 61.689.21). The autonomic status was examined and alterations in CIG in the test with occlusion were evaluated on Varicard hardware and software complex (OOO Ramena, Russia). Results. The obtained data showed the autonomic imbalance with predomination of the activity of sympathetic division of the autonomic nervous system (ANS) in patients with COPD as compared to the control group (p0.05). A study of ergoreflex by analysis of changes in CIG showed reduction of the activity of sympathetic division of the ANS in the test with external peripheral vascular occlusion in individuals without diseases of the respiratory system. In patients with COPD, changes in CIG in the test were less expressed and not always achieved statistically significant level (p0.05). Conclusions. Differences in the results of the test with external peripheral vascular occlusion in patients with COPD and volunteers without diseases of the respiratory system are attributed to hyperactivation of ergofeflex in patents with COPD.


Author(s):  
Philip Wiffen ◽  
Marc Mitchell ◽  
Melanie Snelling ◽  
Nicola Stoner

This chapter outlines information relevant to clinical pharmacists related to respiratory system issues and is loosely based on the British National Formulary, Chapter 3. In particular, this chapter covers current guidelines on asthma management, including a section on inhaler techniques for different products, and management of stable chronic obstructive pulmonary disease.


Author(s):  
Murray Longmore ◽  
Ian B. Wilkinson ◽  
Andrew Baldwin ◽  
Elizabeth Wallin

Signs:Examining the respiratory system –Investigations:Bedside tests in chest medicineFurther investigations in chest medicinePulmonary conditions:PneumoniaSpecific pneumoniasComplications of pneumoniaBronchiectasisCystic fibrosis (cf)Fungi and the lungLung tumoursAsthmaManagement of chronic asthmaChronic obstructive pulmonary disease (...


Sign in / Sign up

Export Citation Format

Share Document